Experimental Medicine

Transpharmation has moved into Clinical CRO work, primarily in our new Irish facilities, in response to client requests for bespoke endpoints that can be compared to the preclinical studies we have conducted for them. Hence, we can now offer a complete set of cross-species capabilities. Whether this might be pharmacoEEG (phEEG), evoked potentials or laser Doppler, we have a suite of capabilities that will allow you to assess the pharmacodynamics and/or efficacy of your molecules.’

Facilities and Technologies
Disease Populations
Microtubule Platform